Company news
Nutriband Inc. (NASDAQ:NTRB) news
Nutriband Inc. news releases on 6ix. Latest, Dec 3, 2021: Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021
Press releases — page 3
Nutriband Inc. to Ring NASDAQ Stock Market Opening Bell on December 3, 2021
December 2, 2021
Nutriband Inc. Initiates Commercial Development of Lead Product AVERSA(TM) Fentanyl
November 15, 2021
Nutriband Inc. Receives Additional $2,062,500 from Exercise of Warrants, Increasing Total Capital from Public Offering and Nasdaq Listing to Approx. $8.7M
October 21, 2021
Nutriband Inc. Signs Exclusive Manufacturing Agreement for Diocheck(TM) Visual COVID-19 Antibody Indicator Patch
October 11, 2021
Nutriband Inc.'s AVERSA(R) technology receives Notice of Allowance from United States Patent and Trademark Office (USPTO)
October 3, 2021
Nutriband Inc. Prices $6.6 million Public Offering and Announces Uplisting to the NASDAQ Capital Market
September 30, 2021
Nutriband Inc. Files Pro Forma Financials Consolidating the Recent Acquisition of Pocono Coated Products Transdermal and Topical Business and Active Intelligence
January 12, 2021
Nutriband Inc. Records Record 375% Year-Over-Year Increase in Third Quarter Revenues and Record 69% Increase for Its Nine Month Revenues
December 15, 2020
Nutriband Inc. Signs Exclusive License Agreement with RAMBAM Hospital Group for its Closed System Transfer Device
December 14, 2020
Nutriband Inc. Receives Notice of Allowance from Korean Intellectual Property Office (KIPO) for its 'Abuse and Misuse Deterrent Transdermal System' Patent
December 9, 2020
Nutriband Inc. Signs Exclusive Distribution Agreement With Oran Textiles for Cifra Reusable V-Block Coated Facemasks
September 14, 2020
Nutriband Inc. Completes Acquisition of Transdermal Manufacturing Business for $7.5 Million
September 1, 2020
Nutriband's AVERSA Trademark Application Receives No Opposition
July 21, 2020
Nutriband Inc. Receives Patent Protection from Australia, Russia and Mexico
March 17, 2020